MicroRNA-4776-5p acts as a radiosensitizer and predicts the prognosis of patients with head and neck cancer receiving radiotherapy
Lai, Y.-L.; Wang, C.-C.; Lin, Y.-L.; Shen, P.-C.; Tsai, M.-H.; Chen, F.-H.; Chang, W.-C.
Show abstract
Head and neck cancer is the leading cancer worldwide. Radiation therapy plays important role of treatment for head and neck cancer. MicroRNAs have been shown to be related to tumor progression and radiosensitivity. However, the mechanisms are still largely unknown and evidence are still limited. In the current study, we sought to identify the miRNA related the radiosensitivity of head and neck tumor cell, which leading to the disappointed prognosis of patients with head and neck cancer receiving radiation therapy. The miRNA expression profiles and clinical information of patients with head and neck cancer were obtained from The Cancer Genome Atlas. The identification of miRNA was carried out through an integrated bioinformatics analysis. The miRNA identified in previous approach was validated through in vitro and in vivo studies. MiR-4776-5p was finally identified as the role of radio-sensitizer and predicts the prognosis of patients with head and neck cancer receiving radiotherapy. 11 of 16 genes targeted by the miR-4776-5p have been discovered to regulate the mechanisms related to radiosensitivity using functional annotation.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Ilomastat contributes to the survival of mouse after irradiation via promoting the recovery of hematopoietic system 97%
- Predictive factors for the development of peritumoral brain edema after LINAC-based radiation treatment in patients with intracranial meningioma 96%
- Biological responses to terahertz radiation with different power density in primary hippocampal neurons 95%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma 93%
- Comparative transcriptome of normal and cancer- associated fibroblasts 93%
- Study Protocol of A Phase II Study to Evaluate Safety and Efficacy of Neo-adjuvant Pembrolizumab and Radiotherapy in Localized Rectal Cancer 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.